RU95107993A - Method for treating sepsis and pyoseptic complications - Google Patents

Method for treating sepsis and pyoseptic complications

Info

Publication number
RU95107993A
RU95107993A RU95107993/14A RU95107993A RU95107993A RU 95107993 A RU95107993 A RU 95107993A RU 95107993/14 A RU95107993/14 A RU 95107993/14A RU 95107993 A RU95107993 A RU 95107993A RU 95107993 A RU95107993 A RU 95107993A
Authority
RU
Russia
Prior art keywords
complications
pyoseptic
sepsis
effectiveness
treating sepsis
Prior art date
Application number
RU95107993/14A
Other languages
Russian (ru)
Other versions
RU2127130C1 (en
Inventor
С.В. Мамаев
А.В. Чижов
Е.Б. Брусина
Original Assignee
Кемеровский кардиологический центр
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кемеровский кардиологический центр filed Critical Кемеровский кардиологический центр
Priority to RU95107993A priority Critical patent/RU2127130C1/en
Publication of RU95107993A publication Critical patent/RU95107993A/en
Application granted granted Critical
Publication of RU2127130C1 publication Critical patent/RU2127130C1/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

FIELD: medicine. SUBSTANCE: method involves administering extremely high antibiotic doses on the background of continuous plasmaphoresis to reach effective bactericidal antibiotic concentrations in blood and tissues, to control bacteriolysis shock development, prevent natural detoxication system from being damaged. EFFECT: enhanced effectiveness of treatment course.

Claims (1)

Изобретение относится к медицине, а именно к интенсивной терапии. Целью изобретения является повышение эффективности лечения сепсиса и гнойно-септических осложнений. Поставленная цель достигается тем, что на фоне непрерывного плазмафереза вводятся сверхвысокие дозы антибиотиков, что позволяет создать эффективные бактерицидные концентрации антибиотиков в крови и тканях, контролировать развитие бактериолизного шока, а также предотвращать повреждение естественных систем детоксикации. Таким образом, данный способ дает возможность достичь поставленную цель, а именно повысить эффективность лечения больных сепсисом и больных с гнойно-септическими осложнениями.The invention relates to medicine, namely to intensive care. The aim of the invention is to increase the effectiveness of the treatment of sepsis and septic complications. This goal is achieved by the fact that against the background of continuous plasmapheresis, ultra-high doses of antibiotics are administered, which allows you to create effective bactericidal concentrations of antibiotics in the blood and tissues, control the development of bacteriolytic shock, and also prevent damage to natural detoxification systems. Thus, this method makes it possible to achieve the goal, namely, to increase the effectiveness of the treatment of patients with sepsis and patients with purulent-septic complications.
RU95107993A 1995-05-17 1995-05-17 Method of treating sepsis and purulo-septic complications RU2127130C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU95107993A RU2127130C1 (en) 1995-05-17 1995-05-17 Method of treating sepsis and purulo-septic complications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU95107993A RU2127130C1 (en) 1995-05-17 1995-05-17 Method of treating sepsis and purulo-septic complications

Publications (2)

Publication Number Publication Date
RU95107993A true RU95107993A (en) 1997-02-27
RU2127130C1 RU2127130C1 (en) 1999-03-10

Family

ID=20167843

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95107993A RU2127130C1 (en) 1995-05-17 1995-05-17 Method of treating sepsis and purulo-septic complications

Country Status (1)

Country Link
RU (1) RU2127130C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2572019C1 (en) * 2014-11-12 2015-12-27 Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" (ГБУЗ МО МОНИКИ им. М.Ф. Владимирского) Method of treating sepsis in treating abdominal organs complicated by hepatic failure

Also Published As

Publication number Publication date
RU2127130C1 (en) 1999-03-10

Similar Documents

Publication Publication Date Title
GEP20002146B (en) Therapeutic Peptide Derivatives
Gustilo Use of antimicrobials in the management of open fractures
Zayat Preliminary experience with topical phenytoin in wound healing in a war zone
DE69736605D1 (en) USE OF TAUROLIDINE OR TAURULTAM FOR THE TREATMENT AND PREVENTION OF INFECTIONS IN MEDICAL RELEASE SYSTEMS
BR0213100A (en) Combinations for the treatment of immunoinflammatory disorders
BR9500436A (en) Products use of a g-csf use of a tnf protein ligand process for the treatment and / or prevention of septic shock
WO2000012049A3 (en) A method for the treatment of staphylococcal disease
ATE259654T1 (en) PHARMACEUTICAL PREPARATIONS FOR THE CONTROL OR PROPHYLAXIS OF SURFACES INFECTED BY MICROORGANISMS
DE69631381T2 (en) THERAPEUTIC AND DIAGNOSTIC AGENTS FOR TREATING MICROBIAL INFECTIONS
Farber Clinical and biological studies with actinomycins
RU95107993A (en) Method for treating sepsis and pyoseptic complications
DE69906928D1 (en) FAT BINDING POLYMERE LIPASE HEMMER COMBINATIONS FOR THE TREATMENT OF GRAVITY
RU2008917C1 (en) Method for purulent wounds treatment
DE69733321D1 (en) OLANZAPINE FOR THE TREATMENT OF DRUG ABUSE
Hamblen Osteomyelitis: Hyperbaric Oxygen in Treatment of Osteomyelitis
RU2000103385A (en) METHOD FOR TREATING ACUTE PANCREOTITIS
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
RU95109747A (en) Method for treating toxic diphtheria
RU94018543A (en) Method for treating the cases of trigeminal nerve neuralgia
RU94020918A (en) Method for treating the cases of opsomenorrhea
RU95106400A (en) Method of prevention and treatment of diphtheria neuropathy in experiment
RU95108457A (en) Method of treatment of severe forms of glps
Alpar Cephradine and flucloxacillin in the prophylaxis of infection in patients with open fractures
RU95104039A (en) Method of vesical disease treatment
RU94037731A (en) Method for treating multiple sclerosis